IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims against CBL & Associates Properties Inc. and Advises Investors with Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)-- Goldberg Law PC (http://www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations by CBL & Associates Properties Inc. (“CBL” or the “Company”) (NYSE: CBL). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.

If you purchased or otherwise acquired CBL shares and would like more information regarding the investigation, we advise you to contact Michael Goldberg or Brian Schall of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles, CA 90067, at 800-977-7401 to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at [email protected].

The investigation concerns whether the Company violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Specifically, the investigation will focus on the May 24, 2016, Wall Street Journal article which reported that CBL is under investigation by the Federal Bureau of Investigation and the Securities and Exchange Commission.

If you have any questions concerning your legal rights in this case, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at [email protected].

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160525006475/en/

Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian Schall, Esq., 800-977-7401
[email protected]
http://www.Goldberglawpc.com
https://twitter.com/search?q=golberglawpc&src=typd
https://www.facebook.com/pages/Goldberg-Law-PC/850505465033804?fref=ts

Source: Goldberg Law PC

You May Also Be Interested In

• FDA approves Merck's KEYTRUDA and WELIREG combination for kidney cancer
• Laser Photonics regains NASDAQ compliance after filing quarterly report
• Venu Holding enters $250 million at-the-market stock offering agreement